Carlos Cordon-Cardo

From WikiMD's WELLNESSPEDIA

Carlos Cordon-Cardo is a pathologist and scientist known for his contributions to the field of oncology. He is currently the Irene Heinz Given and John LaPorte Given Professor and Chair of the Department of Pathology at the Mount Sinai Health System.

Early Life and Education[edit]

Carlos Cordon-Cardo was born in Barcelona, Spain. He completed his medical and doctoral degrees at the University of Barcelona, where he specialized in Pathology and Molecular Genetics.

Career[edit]

Cordon-Cardo moved to the United States in the 1980s, where he began his research career at the Memorial Sloan Kettering Cancer Center. His work primarily focuses on the molecular mechanisms of human cancer, including the role of tumor suppressor genes and oncogenes.

In 2011, he joined the Mount Sinai Health System as the Chair of the Department of Pathology. His current research involves the use of genomics and proteomics to understand the biology of cancer and develop new diagnostic and therapeutic strategies.

Contributions to Oncology[edit]

Cordon-Cardo is known for his pioneering work in the field of oncology. He was one of the first scientists to identify the role of p53, a tumor suppressor gene, in human cancer. His research has also led to the development of new diagnostic tools and treatments for various types of cancer.

Awards and Honors[edit]

Over the course of his career, Cordon-Cardo has received numerous awards and honors for his contributions to the field of oncology. These include the American Cancer Society's Medal of Honor and the National Cancer Institute's Outstanding Investigator Award.

References[edit]


External Links[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Carlos Cordon-Cardo[edit]

  • Carles Cordon-Cardo MD PhD Chair of Pathology at Mount Sinai Hospital
    Carles Cordon-Cardo MD PhD Chair of Pathology at Mount Sinai Hospital

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Carlos_Cordon-Cardo&oldid=6305140"